Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 593,000
-1,000 (-0.17%)
At close: Feb 27, 2026
Hanmi Pharm. Market Cap
Hanmi Pharm. has a market cap or net worth of 7.52 trillion as of February 27, 2026. Its market cap has increased by 153.42% in one year.
Market Cap
7.52T
Enterprise Value
7.89T
Revenue
1.47T
Ranking
n/a
PE Ratio
64.55
Stock Price
593,000.00
Market Cap Chart
Since July 30, 2010, Hanmi Pharm.'s market cap has increased from 680.70B to 7.52T, an increase of 1,004.66%. That is a compound annual growth rate of 16.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 7.52T | 31.19% |
| Dec 30, 2025 | 5.73T | 61.14% |
| Dec 30, 2024 | 3.56T | -20.49% |
| Dec 28, 2023 | 4.47T | 20.54% |
| Dec 29, 2022 | 3.71T | 10.00% |
| Dec 30, 2021 | 3.37T | -23.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yuhan | 8.19T |
| Hanall Biopharma | 3.13T |
| Celltrion Pharm | 3.12T |
| Daewoong Pharmaceutical | 2.03T |
| GC Biopharma | 1.93T |
| Chong Kun Dang Pharmaceutical | 1.23T |
| Ildong Pharmaceutical | 1.22T |
| Daewoong | 1.10T |